DR. THOMAS M. BERGAMINI, M.D.

LOUISVILLE, KY

Research Active
Surgery - Vascular Surgery NPI registered 21+ years 1 publication 2003 – 2003 NPI: 1093719866
Surgery - Vascular Surgery
StrokeStentsRecurrenceAngioplasty, BalloonIschemic Attack, TransientCarotid Stenosis

Practice Location

4003 KRESGE WAY
LOUISVILLE, KY 40207-4652

Phone: (502) 897-5139

What does THOMAS BERGAMINI research?

Dr. Bergamini studies carotid artery disease, a condition where the arteries supplying blood to the brain become narrowed or blocked. His research specifically examines carotid artery stent placement (CAS), which is a procedure that involves inserting a small mesh tube into the artery to keep it open. He evaluates how well this treatment works over time, looking at patient outcomes and the safety of the procedure.

Key findings

  • In a study of 29 patients, 94% remained symptom-free for an average of 28 months after carotid artery stent placement.
  • Only 6% of patients experienced critical artery narrowing again after the procedure.
  • The rate of serious complications from carotid artery stent placement was low, demonstrating its general safety.

Frequently asked questions

Does Dr. Bergamini study carotid artery disease?
Yes, Dr. Bergamini specifically researches carotid artery disease and effective treatments for it.
What treatments has Dr. Bergamini researched?
He has focused on carotid artery stent placement as a treatment for carotid artery disease.
Is Dr. Bergamini's work relevant to patients with carotid artery disease?
Yes, his research is directly relevant to patients suffering from carotid artery disease, highlighting treatment options and outcomes.

Publications in plain English

Intermediate follow-up of carotid artery stent placement.

2003

American journal of surgery

Gable DR, Bergamini T, Garrett WV, Hise J, Smith BL +3 more

Plain English
This study looked at how effective carotid artery stent placement (CAS) is in treating carotid artery disease over a period of time. Out of 29 patients studied, 94% remained symptom-free for an average of 28 months after the procedure, while 6% experienced critical artery narrowing again. The findings show that CAS can be generally safe, with a low rate of serious complications, making it a viable option for treating this condition. Who this helps: This benefits patients with carotid artery disease and their doctors.

PubMed

Frequent Co-Authors

Dennis R Gable Wilson V Garrett Joseph Hise Bertram L Smith William P Shutze Gregory Pearl Brad R Grimsley

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.